Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Blood and Marrow Transplantation for Hematologic Malignancy and Selected Solid Tumors

NCT00060255 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT00060255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00060255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Blood and Marrow Transplantation for Hematologic Malignancy and Selected Solid Tumors
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 2
Overall status
Completed
Start date
December 31, 1991
Completion date
February 28, 2013
Enrollment
451 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, testicular germ cell tumor, unspecified adult solid tumor, protocol specific, unspecified childhood solid tumor, protocol specific